EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circadian-Tuned Peptide Drug/Gene Co-Delivery Nanocomplexes to Enhance Glioblastoma Targeting and Transfection

Ana R Neves, Eric Vivès iD, Prisca Boisguérin iD, Telma Quintela iD, Diana Costa iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ana R Neves und 4 weiteren Autor:innen. Beteiligte Einrichtung: RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Por…. Hauptthemen laut MEDLINE: Glioblastoma, Cell-Penetrating Peptides, Transfection, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia (FCT), Portuguese Foundation for Science and Technology (FCT), CICS-UBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is the most prevalent and aggressive form of brain malignancy. Actual treatments face several challenges due to its high aggressiveness and poor prognosis. The chemotherapeutic agent temozolomide (TMZ) has limited therapeutic efficacy, and mutations in the tumour protein p53 gene (TP53) have been associated with treatment resistance. Thus, this study aimed to explore an innovative therapeutic strategy to enhance treatment efficacy of GBM. Previously, our team had developed a WRAP5 cell-penetrating peptide (CPP) functionalized with a transferrin receptor ligand (Tf) for the targeted delivery of TMZ and a p53-encoding plasmid to glioma cells. Our research had elucidated the circadian oscillations of the clock genes in the U87 glioma cells by employing two different computational models and observed that T16 and T8 time points revealed the highest circadian activity for Bmal1 and Per2 genes, respectively. Similar analysis was conducted for the transferrin receptor, which revealed that T7 and T8 were the key time points for its expression. A confocal microscopy study indicated the highest intracellular uptake of complexes and p53 mRNA expression at T8, the time point with the highest Per2 and transferrin receptor expression. Following mRNA analysis, the evaluation of p53 levels confirmed transcriptional changes at the protein level, and that T16 appears to be a favourable time point for enhancing therapeutic efficacy in U87 glioblastoma cells. These findings suggested that synchronizing the complexes’ administration with the biological clock of GBM cells may significantly improve glioblastoma therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaCell-Penetrating PeptidesTransfectionBrain NeoplasmsCircadian RhythmGene Transfer TechniquesDrug Delivery SystemsHumansCell Line, TumorTumor Suppressor Protein p53TemozolomideReceptors, TransferrinPeriod Circadian ProteinsTransferrinARNTL Transcription Factors

Stichwörter der Autor:innen

TMZ/TP53 systemschronotherapycircadian rhythmsdrug/gene dual therapyglioblastomananotechnology

Substanzen

Cell-Penetrating PeptidesTumor Suppressor Protein p53TemozolomideReceptors, TransferrinPeriod Circadian ProteinsTransferrinARNTL Transcription FactorsPER2 protein, human

Autor:innen und Institutionen

  • RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
  • PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier, France.
  • BRIDGES-Biotechnology Research, Innovation and Design for Health Products, Polytechnic University of Guarda, 6300-559 Guarda, Portugal.

ORCID-Profile: Eric Vivès, Prisca Boisguérin, Telma Quintela, Diana Costa

Förderung

  • Fundação para a Ciência e a Tecnologia (FCT)
  • Portuguese Foundation for Science and Technology (FCT)
  • CICS-UBI
  • Portuguese Platform of BioImaging (PPBI)
  • Agence Nationale de la Recherche
  • “Centre National de la Recherche Scientifique” (CNRS)
  • European Social Fund under the Regional Operational Program Centro

Zitieren

APA

Neves, A. R., Vivès, E., Boisguérin, P., Quintela, T., & Costa, D. (2025). Circadian-Tuned Peptide Drug/Gene Co-Delivery Nanocomplexes to Enhance Glioblastoma Targeting and Transfection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136130

Vancouver

Neves AR, Vivès E, Boisguérin P, Quintela T, Costa D. Circadian-Tuned Peptide Drug/Gene Co-Delivery Nanocomplexes to Enhance Glioblastoma Targeting and Transfection. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136130

BibTeX
@article{Neves2025,
  author = {Neves, Ana R and Vivès, Eric and Boisguérin, Prisca and Quintela, Telma and Costa, Diana},
  title = {Circadian-Tuned Peptide Drug/Gene Co-Delivery Nanocomplexes to Enhance Glioblastoma Targeting and Transfection},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136130}
}
Kostenlos starten →